Activity of crude extract ofRubus crataegifolius roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor
暂无分享,去创建一个
J. Lee | Y. Ham | S. H. Choi | E. Im | J. Jung | K. Im | D. K. Kim | Y. Xu | M. W. Wang | N. D. Kim | Jee H Jung | Dong-Kyoo Kim | Nam Deuk Kim | Ji Hyeon Lee | Min -Wei Wang | Yoon-Ah Ham | Sang-Ho Choi | Ying Xu | S. Choi
[1] J. Cusack,et al. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation. , 2000, Cancer research.
[2] M. Matsuda,et al. Induction of apoptosis and inhibition of DNA topoisomerase-I in K-562 cells by a marine microalgal polysaccharide. , 2000, Life sciences.
[3] N. D. Kim,et al. Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives. , 1999, Cancer letters.
[4] J. Jung,et al. A cyclitol derivative as a replication inhibitor from the marine sponge Petrosia sp. , 1999, Journal of natural products.
[5] H. Chung,et al. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. , 1999, International journal of oncology.
[6] E. Im,et al. A Novel Ursodeoxycholic Acid Derivative Induces Apoptosis in Human MCF-7 Breast Cancer Cells , 1999 .
[7] Christian Jacques,et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer , 1998, The Lancet.
[8] M. S. Orr,et al. Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells. , 1998, Biochemical pharmacology.
[9] M. Fukuoka,et al. Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] N. Saijo,et al. Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Kohn,et al. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. , 1996, Cancer research.
[12] D. Cunningham,et al. Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation. , 1996, European journal of cancer.
[13] Y. Pommier,et al. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. , 1995, Cancer research.
[14] H. Steller. Mechanisms and genes of cellular suicide , 1995, Science.
[15] D. Durham,et al. Antibacterial Activity of Compounds from Rubus pinfaensis , 1994, Planta medica.
[16] Y. Pommier,et al. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. , 1994, Leukemia & lymphoma.
[17] S. Culine,et al. Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. , 1994, Cancer research.
[18] M. Kastan,et al. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways , 1994, Molecular and cellular biology.
[19] L. Liu,et al. DNA topoisomerases: essential enzymes and lethal targets. , 1994, Annual review of pharmacology and toxicology.
[20] E. Podack,et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. , 1993, Biochemical and biophysical research communications.
[21] M. Fukuoka,et al. CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] R. Kasai,et al. Oleanane and ursane glucosides from Rubus species , 1992 .
[23] D. Barron,et al. A 4-hydroxy-β-ionone disaccharide glycoside from raspberry fruits , 1992 .
[24] G. Rastelli,et al. Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase. , 1992, Planta medica.
[25] R. Kasai,et al. Minor diterpene glycosides from sweet leaves of Rubus suavissimus , 1992 .
[26] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[27] O. Tanaka,et al. LABDANE-TYPE DITERPENE GLYCOSIDES FROM FRUITS OF RUBUS-FOLIOLOSUS , 1991 .
[28] K. Son,et al. Triterpenoids from the roots ofRubus parvifolius , 1991 .
[29] L. Liu,et al. DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.
[30] Y. Shu,et al. A triterpene from the fruits of Rubus chingii , 1988 .
[31] W. Chou,et al. Diterpene glycosides from leaves of Chinese Rubus chingii and fruits of R. suavissimus, and identification of the source plant of the Chinese folk medicine "fu-pen-zi". , 1987, Chemical & pharmaceutical bulletin.
[32] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[33] F. Gao,et al. 19α-Hydroxyursane-Type Triterpene Glucosyl Esters from the Roots of Rubus suavissimus S. LEE , 1985 .
[34] W. Henning. Flavonolglykoside der Erdbeeren (Fragaria x ananassa Duch.), Himbeeren (Rebus idaeus L.) und Brombeeren (Rubes fruticosus L.) , 1981 .
[35] S. Ganguly,et al. Rubinic acid, a triterpene acid from rubus fruticosus , 1978 .
[36] S. Ganguly. Sterols and triterpenes from Rubus fruticosus , 1972 .